This Article Full Text Full Text (PDF) All Versions of this Article: 145/1/104    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kariagina, A. Articles by Chesnokova, V. Search for Related Content PubMed PubMed Citation Articles by Kariagina, A. Articles by Chesnokova, V.

Hypothalamic-Pituitary Cytokine Network

Cedars-Sinai Medical Center-University of California, Los Angeles School of Medicine, Los Angeles, California 90048

Address all correspondence and requests for reprints to: Vera Chesnokova, Ph.D., Department of Medicine, Division of Endocrinology, Davis Building, Room 3019, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, California 90048. E-mail: chesnokovav{at}cshs.org.

Cytokines expressed in the brain and involved in regulating the hypothalamus-pituitary-adrenal (HPA) axis contribute to the neuroendocrine interface. Leukemia inhibitory factor (LIF) and LIF receptors are expressed in human pituitary cells and murine hypothalamus and pituitary. LIF potently induces pituitary proopiomelanocortin (POMC) gene transcription and ACTH secretion and potentiates CRH induction of POMC. In vivo, LIF, along with CRH, enhances POMC expression and ACTH secretion in response to emotional and inflammatory stress. To further elucidate specific roles for both CRH and LIF in activating the inflammatory HPA response, double-knockout mice (CRH/LIFKO) were generated by breeding the null mutants for each respective single gene. Inflammation produced by ip injection of lipopolysaccharide (1 µg/mouse) to double CRH and LIF-deficient mice elicited pituitary POMC induction similar to wild type and markedly higher than in single null animals (P < 0.0.01). Double-knockout mice also demonstrated robust corticosterone response to inflammation. High pituitary POMC mRNA levels may reflect abundant TNF, IL-1ß, and IL-6 activation observed in the hypothalamus and pituitary of these animals. Our results suggest that increased central proinflammatory cytokine expression can compensate for the impaired HPA axis function and activates inflammatory ACTH and corticosterone responses in mice-deficient in both CRH and LIF.

This article has been cited by other articles:

				R. Jankord, J. R. Turk, J. C. Schadt, J. Casati, V. K. Ganjam, E. M. Price, D. H. Keisler, and M. H. Laughlin Sex Difference in Link between Interleukin-6 and Stress Endocrinology, August 1, 2007; 148(8): 3758 - 3764. [Abstract] [Full Text] [PDF]

				L. Daza, R. Martin-Jimenez, P. X De la Torre, E. Hernandez, and B. Murillo Improvement of ACTH response to insulin tolerance test in female patients with rheumatoid arthritis due to tumor necrosis factor inhibition Eur. J. Endocrinol., July 1, 2007; 157(1): 47 - 51. [Abstract] [Full Text] [PDF]

				I. V. Mikhaylova, T. Kuulasmaa, J. Jaaskelainen, and R. Voutilainen Tumor Necrosis Factor-{alpha} Regulates Steroidogenesis, Apoptosis, and Cell Viability in the Human Adrenocortical Cell Line NCI-H295R Endocrinology, January 1, 2007; 148(1): 386 - 392. [Abstract] [Full Text] [PDF]

				A. I Arroba, A. M Lechuga-Sancho, L. M Frago, J. Argente, and J. A Chowen Increased apoptosis of lactotrophs in streptozotocin-induced diabetic rats is followed by increased proliferation. J. Endocrinol., October 1, 2006; 191(1): 55 - 63. [Abstract] [Full Text] [PDF]

				R. Janoschek, L. Plum, L. Koch, H. Munzberg, S. Diano, M. Shanabrough, W. Muller, T. L. Horvath, and J. C. Bruning gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor PNAS, July 11, 2006; 103(28): 10707 - 10712. [Abstract] [Full Text] [PDF]

				K. Zacharowski, P. A. Zacharowski, A. Koch, A. Baban, N. Tran, R. Berkels, C. Papewalis, K. Schulze-Osthoff, P. Knuefermann, U. Zahringer, et al. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome PNAS, April 18, 2006; 103(16): 6392 - 6397. [Abstract] [Full Text] [PDF]

				A. Kariagina, S. Zonis, M. Afkhami, D. Romanenko, and V. Chesnokova Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E857 - E863. [Abstract] [Full Text] [PDF]

				V. Chesnokova, K. Kovacs, A.-V. Castro, S. Zonis, and S. Melmed Pituitary Hypoplasia in Pttg-/- Mice Is Protective for Rb+/- Pituitary Tumorigenesis Mol. Endocrinol., September 1, 2005; 19(9): 2371 - 2379. [Abstract] [Full Text] [PDF]

				L. Daheron, S. L. Opitz, H. Zaehres, W. M. Lensch, P. W. Andrews, J. Itskovitz-Eldor, and G. Q. Daley LIF/STAT3 Signaling Fails to Maintain Self-Renewal of Human Embryonic Stem Cells Stem Cells, September 1, 2004; 22(5): 770 - 778. [Abstract] [Full Text] [PDF]